Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,104 | 146,066 | 133,060 | 94,817 | 60,093 |
| Marketable Securities | 117,796 | 33,796 | 33,798 | 33,917 | 47,180 |
| Receivables | 60,034 | 54,704 | 43,606 | 53,327 | 47,487 |
| Inventories | 64,577 | 64,902 | 67,136 | 63,715 | 59,346 |
| Other current assets | 0 | 1 | 0 | 0 | 0 |
| TOTAL | $295,511 | $299,469 | $277,600 | $245,776 | $214,106 |
| Non-Current Assets | |||||
| PPE Net | 6,880 | 7,233 | 7,475 | 7,965 | 7,770 |
| Investments And Advances | 8,113 | 8,647 | 6,673 | 6,698 | 5,922 |
| Intangibles | 130,988 | 135,538 | 134,926 | 135,901 | 138,863 |
| Other Non-Current Assets | 47,874 | 49,076 | 47,112 | 49,919 | 36,520 |
| TOTAL | $193,855 | $200,494 | $196,186 | $200,483 | $189,075 |
| Total Assets | $489,365 | $499,963 | $473,785 | $446,259 | $403,181 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,375 | 5,336 | 5,210 | 5,105 | 4,555 |
| Accounts payable and accrued liabilities | 103,526 | 105,899 | 78,221 | 78,382 | 68,748 |
| Other current liabilities | 675 | 1,187 | N/A | N/A | N/A |
| TOTAL | $112,346 | $115,791 | $87,914 | $87,942 | $77,536 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 108,060 | 107,214 | 121,228 | 118,766 | 110,524 |
| TOTAL | $108,060 | $107,070 | $121,228 | $118,766 | $110,355 |
| Total Liabilities | $220,405 | $222,861 | $209,141 | $206,708 | $187,891 |
| Shareholders' Equity | |||||
| Common Shares | 8,065 | 8,009 | 7,953 | 7,821 | 7,806 |
| Retained earnings | -281,455 | -272,983 | -276,878 | -286,031 | -292,801 |
| Other shareholders' equity | 23,749 | 28,819 | 25,852 | 25,908 | 9,984 |
| TOTAL | $268,960 | $277,102 | $264,644 | $239,551 | $215,290 |
| Total Liabilities And Equity | $489,365 | $499,963 | $473,785 | $446,259 | $403,181 |